Travoprost in children: adverse effects and intraocular pressure response.

Journal Article

Because of the limited ability to perform controlled, randomized studies in children, the safety and effectiveness of topical medications in pediatric glaucoma is sometimes difficult to determine. Although travoprost has been commercially available since 2001, there are no published reports on its use in children. This retrospective study found travoprost to have minimal adverse events in children and to reduce IOP in select cases of pediatric glaucoma.

Full Text

Duke Authors

Cited Authors

  • Yanovitch, TL; Enyedi, LB; Schotthoeffer, EO; Freedman, SF

Published Date

  • February 2009

Published In

Volume / Issue

  • 13 / 1

Start / End Page

  • 91 - 93

PubMed ID

  • 19233013

Electronic International Standard Serial Number (EISSN)

  • 1528-3933

Digital Object Identifier (DOI)

  • 10.1016/j.jaapos.2008.08.006

Language

  • eng

Conference Location

  • United States